Ascletis Pharma Inc. announces dosing of 24 healthy subjects of the first 3 cohorts in multiple-dose escalation Phase I clinical trial of oral RNA-dependent...
The preliminary results of the first-in-human (FIH) trials for the innovative ELANA Heart Bypass Solution have been unveiled and look promising.
At the 36th EACTS...
Phagenesis Ltd, announced that the U.S. Food and Drug Administration (FDA) has granted a De Novo request for the Phagenyx Neurostimulation System, a first-of-its-kind...
ALCOR, a French company specialized in the design, development, and manufacturing of innovative medical devices, and Merck KGaA, Darmstadt, Germany, a leading science, and...
